"San Juan Oncology Associates (SJOA) is the hub of cancer and hematology patient care and clinical research serving the Four Corners Area. In tandem with the San Juan Regional Medical Center and its Radiation Oncology service housed next door, we bring a complete range of diagnostic, chemotherapeutic, radiation and support services to the treatment of cancer and blood-related diseases."

During the past decade, San Juan Oncology Associates conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 31 clinical trials were completed, i.e. on average, 79.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 19 clinical trials were completed. i.e. 146.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Juan Oncology Associates" #1 sponsor was "Genentech, Inc." with 13 trials, followed by "Hoffmann-La Roche" with 12 trials sponsored, "Seagen Inc." with 4 trials sponsored, "Millennium Pharmaceuticals, Inc." with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Juan Oncology Associates" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "San Juan Oncology Associates" are "Multiple Myeloma" (5 trials), "Breast Cancer" (4 trials), "Non-Small Cell Lung Cancer" (4 trials), "COVID-19 Pneumonia" (3 trials) and "Lymphoma, Non-Hodgkin" (3 trials). Many other conditions were trialed in "San Juan Oncology Associates" in a lesser frequency.

Most popular intervention types in "San Juan Oncology Associates" are "Drug" (58 trials), "Other" (4 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Atezolizumab" (6 trials), "Obinutuzumab" (6 trials), "Cyclophosphamide" (5 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "San Juan Oncology Associates" are 57 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "San Juan Oncology Associates". undefined are not yet recruiting, 5 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in San Juan Oncology Associates, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in San Juan Oncology Associates, 6 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".